Page last updated: 2024-11-07

dextroamphetamine and Diabetes Mellitus, Type 1

dextroamphetamine has been researched along with Diabetes Mellitus, Type 1 in 1 studies

Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.

Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kapellen, TM1
Reimann, R1
Kiess, W1
Kostev, K1

Other Studies

1 other study available for dextroamphetamine and Diabetes Mellitus, Type 1

ArticleYear
Prevalence of medically treated children with ADHD and type 1 diabetes in Germany - Analysis of two representative databases.
    Journal of pediatric endocrinology & metabolism : JPEM, 2016, Nov-01, Volume: 29, Issue:11

    Topics: Adolescent; Age Factors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; C

2016